Tolterodine Tartrate 1 mg Film-coated Tablet Irska - engleski - HPRA (Health Products Regulatory Authority)

tolterodine tartrate 1 mg film-coated tablet

accord healthcare ireland ltd. - tolterodine tartrate - film-coated tablet - 1 milligram(s) - drugs for urinary frequency and incontinence; tolterodine

Tolterodine Tartrate 2 mg Film-coated Tablet Irska - engleski - HPRA (Health Products Regulatory Authority)

tolterodine tartrate 2 mg film-coated tablet

accord healthcare ireland ltd. - tolterodine tartrate - film-coated tablet - 2 milligram(s) - drugs for urinary frequency and incontinence; tolterodine

TOLTERODINE TARTRATE tablet, film coated Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

tolterodine tartrate tablet, film coated

remedyrepack inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate, are metabolized to 5-hydroxymethyl tolterodine.

TOLTERODINE TARTRATE- tolterodine tartrate tablet, film coated Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

tolterodine tartrate- tolterodine tartrate tablet, film coated

remedyrepack inc. - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tablets are also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tablets, are metabolized to 5-hydroxymethyl tolterodine.